William Orr to Treatment Outcome
This is a "connection" page, showing publications William Orr has written about Treatment Outcome.
Connection Strength
0.390
-
Predictors and patterns of insomnia symptoms in OSA before and after PAP therapy. Sleep Med. 2014 Aug; 15(8):899-905.
Score: 0.072
-
Effects of mosapride on secondary peristalsis in patients with ineffective esophageal motility. Scand J Gastroenterol. 2013 Dec; 48(12):1363-70.
Score: 0.069
-
The effect of baclofen on nocturnal gastroesophageal reflux and measures of sleep quality: a randomized, cross-over trial. Neurogastroenterol Motil. 2012 Jun; 24(6):553-9, e253.
Score: 0.062
-
Acidic and non-acidic reflux during sleep under conditions of powerful acid suppression. Chest. 2007 Feb; 131(2):460-5.
Score: 0.044
-
The effect of 1 week of continuous positive airway pressure treatment in obstructive sleep apnea patients with concomitant gastroesophageal reflux. Chest. 2006 Oct; 130(4):1003-8.
Score: 0.043
-
Therapeutic options in the treatment of nighttime gastroesophageal reflux. Digestion. 2005; 72(4):229-38.
Score: 0.040
-
Patterns of 24-hour oesophageal acid exposure after acute withdrawal of acid suppression. Aliment Pharmacol Ther. 1995 Oct; 9(5):571-4.
Score: 0.020
-
The effect of dexlansoprazole MR on nocturnal heartburn and GERD-related sleep disturbances in patients with symptomatic GERD. Am J Gastroenterol. 2011 Mar; 106(3):421-31.
Score: 0.014
-
Effect of esomeprazole on nighttime heartburn and sleep quality in patients with GERD: a randomized, placebo-controlled trial. Am J Gastroenterol. 2005 Sep; 100(9):1914-22.
Score: 0.010
-
Rabeprazole in nonerosive gastroesophageal reflux disease: a randomized placebo-controlled trial. Am J Gastroenterol. 2002 Jun; 97(6):1332-9.
Score: 0.008
-
Efficacy of a motilin receptor agonist (ABT-229) for the treatment of gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2002 Apr; 16(4):749-57.
Score: 0.008